Contact Us News & Media Font Size Home About Us Products Research Responsibility Investor Relations News & Media Careers PARTNERING Core Strengths Executive Team Board of Directors 150th Anniversary Our Story Inclusion and Diversity Partnering Suppliers News & Media Blog Patient Stories Careers at Mallinckrodt Community Outreach Investor Relations Strategic Focus on Growth Through Partnerships Mallinckrodt Pharmaceuticals is committed to bringing new and innovative products to the market. When you partner with us, you become part of the greater effort to make the world a healthier place by providing patients with safer and more effective products. We are continuously looking for opportunities to expand our diverse product and business portfolios through: Targeted acquisitions Development collaborations Licensing arrangements In our pursuit of new business opportunities at Mallinckrodt, we follow a rigorous and well-defined process to select and evaluate new ideas, execute business transactions and integrate external opportunities. Areas of Interest We are primarily seeking commercialized or late-stage products for our Specialty Brands and Specialty Generics segments within the following key areas: Neurology (CNS), nephrology, rheumatology, ophthalmology, pulmonology, or rare disease products Acute care in-patient hospital products Select acute care office-based products Specialty/niche and controlled generics To learn more about Mallinckrodt Pharmaceuticals' products, visit our products website. Our Process We follow a standard external idea selection process and rigorously evaluate new growth opportunities to drive and support partnership negotiations. Step 1: Initial Review Conduct initial review of non-confidential information Determine if opportunity aligns with strategic focus areas Execute a confidentiality agreement if we move forward Step 2: Due Diligence Conduct in-depth assessments of confidential information in areas such as finance, commercial, manufacturing, intellectual property, and R&D Step 3: Transaction Execution Negotiate and obtain approval for transaction Execute transaction Step 4: Implementation Transition, integrate, and operationalize Should you have an opportunity that fits Mallinckrodt's focus areas for our consideration, please contact us. Building On Our Heritage 150 years of quality, integrity and service. Learn More Our Culture From philanthropic efforts to advocacy initiatives, we are living our hallmarks throughout our communities. Learn How Resources for: Career Seekers Investors Suppliers About Mallinckrodt: About Us Home Investor Relations News & Media Products Research Responsibility Other Links: Blog Calif. Supply Chain Disclosure Contact Us Patents Privacy Policy Safety Data Sheets Terms of Use UK Modern Slavery Act Disclosure Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Blog LinkedIn + Cookies Policy Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies setting, please read our Privacy Policy. By continuing to browse the site, you are agreeing to accept our use of cookies. I Agree ›